Background COVID-19 is known as a new viral infection. Viral-bacterial co-infections are one
of the biggest medical concerns, resulting in increased mortality rates. To date, few studies …

Since Dec. 2019 the new coronavirus (SARS-CoV-2) has infected millions and claimed life
of several hundred thousand worldwide. However, so far no approved vaccine or drug …

Background We aimed to analyze the prognostic power of CT-based radiomics models using
data of 14,339 COVID-19 patients. Methods Whole lung segmentations were performed …

Background: Interleukin-6 (IL-6) is one of the inflammatory mediators characterized by elevated
levels in ischemic stroke (IS) patients. The present study set out to assess the role of IL-6, …

The novel coronavirus, formerly named as 2019 novel coronavirus (2019-nCov) caused a
rapidly spreading epidemic of severe acute respiratory syndrome (SARS) in Wuhan, China …

… ∗ † , Elyar Sadeghi-Hokmabadi MD ∗ † , Sina Zarrintan MD § || , Ehsan Sharifipour MD ∗ †
… Sharifi-Bonab and Sharifipour contributed to the conduction of trial. Dr. Zarrintan contributed …

Background Despite the prevalence of chest CT in the clinic, concerns about unoptimized
protocols delivering high radiation doses to patients still remain. This study aimed to assess …

Purpose To derive and validate an effective radiomics-based model for differentiation of
COVID-19 pneumonia from other lung diseases using a very large cohort of patients. Methods …

Potential therapeutic approaches in coronavirus disease 2019 (COVID-19) comprise antiviral
and immunomodulatory agents; however, no immunomodulator drug has been approved. …

… Ehsan Sharifipour and Samira Khani designed … Ehsan Sharifipour had an effective role in
the implementation of this study and the data collection. Samira Khani and Ehsan Sharifipour …